Alzheimer’s Drug Poses a Dilemma for the F.D.A. June 5, 2021 Auto Bot alzheimer's disease, Biogen Inc, Brain, Clinical Trials, elderly, Food and Drug Administration, memory, your-feed-healthcare, your-feed-science 0 If the agency approves it, aducanumab would be the first new Alzheimer’s treatment since 2003. Patients are desperate for new options, but some scientists say there isn’t enough evidence it works.